ETR/AG8 (ETR/AG8)

Deutsche Börse Xetra: ETR/AG8 · EUR

€163

+3.15 (+2.0%)· Recorded snapshot

Market cap	45.8B
Revenue (ttm)	6.4B
Net income (ttm)	1.3B
EPS (ttm)	€4.56
P/E (trailing)	35.6x
P/E (forward)	26.9x
Dividend	€0.89 (0.55%)
Volume	201

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.4B
Net income (ttm): 1.3B
EPS (ttm): €4.56
P/E (trailing): 35.6x
P/E (forward): 26.9x
Market cap: 45.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E26.9

P25 n/aP50 n/aP75 n/a

Trailing P/E35.6

P25 n/aP50 n/aP75 n/a

ROE21

P25 n/aP50 n/aP75 n/a

ROIC16.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ETR/AG8 indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-25
Employees	18,200
Employees change	0
Employees growth	0%
Enterprise value	EUR 47.9B
Exchange	Deutsche Börse Xetra
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-07-12
Fiscal year end	October
Founded	1999
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	US00846U1016
Last earnings date	2026-08-26
Last refreshed	2026-10-28
Market cap	EUR 45.8B
Next earnings date	2026-11-25
Price	EUR 162.50
Price currency	EUR
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	etr/AG8
Website	https://www.agilent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	37.11x
Average P/E ratio (3Y)	28.72x
Average P/E ratio (5Y)	30.28x
Earnings yield	2.81%
EV/Earnings	37.59x
EV/EBIT	28.98x
EV/EBITDA	24.65x
EV/FCF	42.72x
EV/Sales	7.11x
FCF / EV yield	2.34%
FCF yield	2.45%
Forward P/E	26.94x
Graham number	47.64023
Graham upside	-70.1%
Lynch fair value	EUR 34.56
Lynch upside	-78.31%
P/(FCF - SBC) ratio	45.48x
P/(OCF - SBC) ratio	34.95x
P/B ratio	7.02x
P/E ratio	35.64x
P/FCF ratio	40.78x
P/OCF ratio	32.11x
P/S ratio	7.01x
Price / tangible book value	36.2x
Price/EBITDA ratio	24.84x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.54%
EBITDA margin	28.21%
Effective tax rate	13.15%
FCF margin	16.62%
Gross margin	53.65%
Operating margin	24.54%
Pretax margin	22.49%
Profit margin	19.53%
Profit per employee	EUR 68,780
Profitable quarters	34
Profitable years	16
Revenue per employee	EUR 352,114
ROA	8.63%
ROA (5Y)	8.87%
ROCE	15.49%
ROE	20.97%
ROE (5Y)	22.37%
ROIC	16.89%
ROIC (5Y)	18.9%
SBC / revenue	1.78%
Tax / revenue	2.96%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	18.4%
EPS growth (Q)	8.48%
EPS growth (QoQ)	6.67%
EPS growth 10Y	13.4%
EPS growth 3Y	9.87%
EPS growth 5Y	9.59%
EPS growth quarters	2
EPS growth years	5
FCF growth	16.45%
FCF growth (Q)	69.5%
FCF growth (QoQ)	118.41%
FCF growth 3Y	-3.73%
FCF growth 5Y	-0.02%
Gross profit growth	10.51%
Gross profit growth (Q)	16.54%
Gross profit growth 3Y	3.55%
Gross profit growth 5Y	3.72%
Net income growth	18.03%
Net income growth (Q)	7.74%
Net income growth (QoQ)	6.78%
Net income growth 3Y	8.32%
Net income growth 5Y	7.78%
Net income growth quarters	2
Net income growth years	2
OCF growth	7.63%
OCF growth (Q)	43.37%
OCF growth (QoQ)	87.36%
OCF growth 10Y	7.24%
OCF growth 3Y	-1.89%
OCF growth 5Y	2.52%
Operating income growth	13.77%
Operating income growth (Q)	21.52%
Operating income growth 3Y	0.26%
Operating income growth 5Y	6.72%
Revenue growth	8.6%
Revenue growth (Q)	8.06%
Revenue growth (QoQ)	2.34%
Revenue growth 10Y	5.98%
Revenue growth 3Y	1.77%
Revenue growth 5Y	3.72%
Revenue growth quarters	8
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -297.3M
Depreciation and amortization	EUR 243.6M
EBIT	EUR 1.6B
EBITDA	EUR 1.8B
EPS	EUR 4.56
Financing cash flow	EUR -82.6M
Free cash flow	EUR 1.1B
Free cash flow minus SBC	EUR 987.5M
Gross profit	EUR 3.4B
Income taxes	EUR 189.5M
Investing cash flow	EUR -1.1B
Net borrowing	EUR 481.9M
Net cash flow	EUR 193.9M
Net income	EUR 1.3B
Operating cash flow minus SBC	EUR 1.3B
Operating income	EUR 1.6B
Revenue	EUR 6.4B
Stock-based compensation	EUR 113.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.69
Book value per share	EUR 22.70
Debt / EBITDA	1.95
Debt / equity	0.56
Debt / FCF	3.27
Goodwill	EUR 4.5B
Interest coverage	17.07
Long-term assets	EUR 7.9B
Long-term liabilities	EUR 3.7B
Net cash (debt)	EUR -2.1B
Net cash / market cap	-4.63%
Net debt / EBITDA	1.15
Net debt / equity	0.32
Net debt / FCF	1.89
Piotroski F-Score	5
Property, plant and equipment	EUR 2.1B
Shareholders' equity	EUR 6.4B
Tangible book value	EUR 1.2B
Tangible book value per share	EUR 4.40
Total assets	EUR 12.1B
Total cash	EUR 1.5B
Total debt	EUR 3.6B
Total liabilities	EUR 5.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current assets	EUR 4.2B
Current liabilities	EUR 2.1B
Current ratio	2.05
Inventory turnover	3.21
Net working capital	EUR 825.8M
Quick ratio	1.41
Working capital	EUR 2.1B
Working capital turnover	2.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.53%
Dividend growth	321.08%
Dividend growth (3Y)	61.48%
Dividend growth (5Y)	33.31%
Dividend growth years	1
Dividend payment date	2026-10-28
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.89
Dividend yield	0.55%
Ex-dividend date	2026-10-06
Last dividend	EUR 0.23
Payout ratio	19.86%
Shareholder yield	1.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	1.98%
1M price change	5.53%
1M total return	5.69%
1W price change	4.01%
1W total return	4.01%
20-day SMA	EUR 153.88
3M price change	31.37%
3M total return	31.57%
50-day SMA	EUR 142.69
52-week high	EUR 162.50
52-week high date	2026-10-28
52-week low	EUR 109.85
52-week low date	2026-06-17
All-time high	EUR 163.00
All-time high date	2026-10-28
All-time low	EUR 109.85
All-time low date	2026-06-17
Average true range (ATR)	EUR 2.97
Average volume	36.2
Change from 52-week high	0%
Change from 52-week low	47.93%
Change from all-time high	-0.31%
Change from all-time low	45.06%
Change from open	2.39%
Day's gap	-0.41%
Dollar volume	EUR 32,663
High price	EUR 163.00
Low price	EUR 158.70
Monthly RSI	0
Open price	EUR 158.70
Position in 52-week range	88.37%
Previous close	EUR 159.35
Price vs 20-day SMA	3.56%
Price vs 50-day SMA	11.68%
Relative volume	7.67
RSI	68.09
Sharpe ratio	2.89
Sortino ratio	5.9
Volume	201
Weekly RSI	77.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	281.2M
Shares change (QoQ)	0%
Shares change (YoY)	-0.53%
Shares held by insiders	0.16%
Shares held by institutions	94.18%
Short ratio	2.3 days

Deeper analysis on ETR/AG8

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ETR/AG8 report

Is a complete ETR/AG8 research report available?

No complete published report is available for etr/AG8 (ETR/AG8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ETR/AG8 (ETR/AG8)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/AG8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/AG8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ETR/AG8

Frequently asked questions